Consistently, no significant correlation was detected between CD200, or CD276 expression, and the other immune checkpoints (Figure 3B, Figure S4D), which suggested that expression of CD200 and CD276 may be independently regulated, and that heterogeneity may still exist in cancer stem cell population, particularly in the aspect of immune checkpoint. This evidence concerns the gene CD276 and cancer.